JPRN-UMIN000002128已完成未知
Anti-VEGF combined with Verteporfin photodynamic therapy in age-related macular degeneration(AMD) - Conbination therapy for AMD
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •subjects with systemic risk factors
研究者
相似试验
已完成
2 期
Photodynamic therapy with half dose verteporfin for central serous chorioretinopathy:Prospective intervention trialCentral serous chorioretinopathyJPRN-UMIN000002229agoya University School of Medicine Department of Ophthalmology10
进行中（未招募）
1 期
A Phase 1 Trial of Verteporfin Photodynamic Therapy in Unresectable Pancreatic Carcinoma (VERTPAC-01 study) - VERTPAC-01EUCTR2006-004097-28-GBniversity College Hospitals NHS Foundation Trust/ University College London12
终止
2 期
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)Macular DegenerationChoroidal NeovascularizationNCT00433017Novartis255
尚未招募
不适用
Verteporfin photodynamic therapy for central serous chorioretinopathyCentral serous chorioretinopathyJPRN-UMIN000020677Kansai Medical University30
已完成
不适用
Photodynamic Therapy With Verteporfin for Corneal NeovascularizationCorneal NeovascularizationNCT00471406Chonnam National University Hospital